CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $369,000 | -36.9% | 138,123 | +2.2% | 0.03% | -28.9% |
| Q4 2021 | $585,000 | +8.5% | 135,123 | +27.7% | 0.04% | +15.4% |
| Q3 2021 | $539,000 | +12.5% | 105,808 | +39.7% | 0.04% | +21.9% |
| Q2 2021 | $479,000 | +38.8% | 75,744 | +69.8% | 0.03% | +28.0% |
| Q1 2021 | $345,000 | -37.6% | 44,612 | -47.2% | 0.02% | -32.4% |
| Q4 2020 | $553,000 | -23.1% | 84,434 | -21.9% | 0.04% | -21.3% |
| Q3 2020 | $719,000 | -23.3% | 108,098 | -3.9% | 0.05% | -26.6% |
| Q2 2020 | $937,000 | +55.1% | 112,519 | +43.0% | 0.06% | +33.3% |
| Q1 2020 | $604,000 | -26.0% | 78,700 | -19.8% | 0.05% | -4.0% |
| Q4 2019 | $816,000 | +22.9% | 98,157 | +9.0% | 0.05% | +28.2% |
| Q3 2019 | $664,000 | – | 90,037 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |